Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lysine demethylase 6A | 0.498 | 0.769 | 1.00 |
|
group | 0.600 | None | 1.000 | 0 | 0 | 2009 | 2019 | ||||||||
|
colony stimulating factor 1 receptor | 0.448 | 0.808 | 0.13 |
|
group | 0.600 | None | 1.000 | 0 | 0 | 1992 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.600 | None | 0.972 | 0 | 0 | 1987 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.600 | None | 0.946 | 0 | 0 | 1994 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.600 | None | 0.979 | 0 | 0 | 1984 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.600 | None | 0.968 | 0 | 0 | 1993 | 2020 | ||||||||
|
UDP glucuronosyltransferase family 1 member A1 | 0.464 | 0.769 | 3.3E-06 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1997 | 2020 | ||||||||
|
ATR serine/threonine kinase | 0.456 | 0.923 | 3.5E-09 |
|
group | 0.400 | None | 0.965 | 0 | 0 | 1999 | 2020 | ||||||||
|
phosphoinositide-3-kinase regulatory subunit 1 | 0.477 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.923 | 0 | 0 | 2001 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
group | 0.400 | None | 0.946 | 0 | 0 | 2002 | 2019 | ||||||||
|
cyclin E1 | 0.538 | 0.731 | 0.97 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.400 | None | 0.986 | 0 | 0 | 1999 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1988 | 2020 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.943 | 0 | 0 | 1999 | 2019 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
group | 0.400 | None | 0.903 | 0 | 0 | 1998 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 1991 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 0.978 | 0 | 0 | 1989 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.975 | 0 | 0 | 1992 | 2020 | ||||||||
|
cyclin D3 | 0.554 | 0.654 | 0.98 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1995 | 2019 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2004 | 2019 | ||||||||
|
WRN RecQ like helicase | 0.524 | 0.808 | 2.6E-34 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
group | 0.400 | None | 0.959 | 0 | 0 | 1989 | 2019 |